GALMED PHARMACEUTICALS LTD. Diluted Shares Outstanding (Weighted Average)
GALMED PHARMACEUTICALS LTD. (GLMD) reported Diluted Shares Outstanding (Weighted Average) of 952.17 thousand shares for the 3-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 952.17K shares, a 92.93% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 6.02M shares, a 274.31% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 5.46M shares, a 558.29% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 493.52K shares, a 27.19% decline year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 952.17K shares 6-K · filed 2026-09-02 | 888.76K shares 6-K · filed 2026-09-02 | |||||
| 2025-12-31 | 6.02M shares derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | 5.74M shares derived: average of 2 quarters · filed 2026-03-31 | 3.99M shares derived: average of 3 quarters · filed 2026-09-02 | 4.31M shares 20-F · filed 2026-03-31 | |||
| 2025-09-30 | 5.46M shares 6-K · filed 2025-11-26 | 2.98M shares derived: average of 2 quarters · filed 2026-09-02 | 3.74M shares 6-K · filed 2025-11-26 | ||||
| 2025-06-30 | 493.52K shares 6-K · filed 2026-09-02 | 3.95M shares 6-K · filed 2025-08-28 | 358.32K shares 6-K · filed 2026-09-02 | 2.87M shares 6-K · filed 2025-08-28 | |||
| 2024-12-31 | 1.61M shares derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | 1.22M shares derived: average of 2 quarters · filed 2026-03-31 | 1.04M shares derived: average of 3 quarters · filed 2026-03-31 | 930.82K shares 20-F · filed 2026-03-31 | |||
| 2024-09-30 | 829.50K shares 6-K · filed 2025-11-26 | 753.68K shares derived: average of 2 quarters · filed 2025-11-26 | 705.43K shares 6-K · filed 2025-11-26 | ||||
| 2024-06-30 | 677.86K shares 6-K · filed 2025-08-28 | 6.29M shares 6-K · filed 2024-08-28 | 643.17K shares 6-K · filed 2025-08-28 | 5.88M shares 6-K · filed 2024-08-28 | |||
| 2023-12-31 | 230.79K shares 20-F · filed 2026-03-31 | 2.77M shares 20-F · filed 2024-04-04 | |||||
| 2023-06-30 | 1.68M shares 6-K · filed 2024-08-28 | 1.68M shares 6-K · filed 2024-08-28 | |||||
| 2022-12-31 | 139.68K shares 20-F · filed 2025-04-02 | 25.14M shares 20-F · filed 2023-03-29 | |||||
| 2022-06-30 | 1.67M shares 6-K · filed 2023-08-09 | 25.09M shares 6-K · filed 2022-08-04 | 1.67M shares 6-K · filed 2023-08-09 | 25.09M shares 6-K · filed 2022-08-04 | |||
| 2021-12-31 | 1.64M shares 20-F · filed 2024-04-04 | 24.60M shares 20-F · filed 2022-05-02 | |||||
| 2021-06-30 | 25.08M shares 6-K · filed 2022-08-04 | 24.10M shares 6-K · filed 2022-08-04 | |||||
| 2020-12-31 | 21.28M shares 20-F · filed 2023-03-29 | ||||||
| 2019-12-31 | 21.11M shares 20-F · filed 2022-05-02 |